Published in

Elsevier, Journal of Clinical Lipidology, 2(10), p. 368-377, 2016

DOI: 10.1016/j.jacl.2015.12.021

Links

Tools

Export citation

Search in Google Scholar

Non–high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglyceride levels in the Arabian Gulf

Journal article published in 2015 by Khamis Al-Hashmi, Ibrahim Al-Zakwani, Wael Al Mahmeed, Wael Al Mahmeed, Mohamed Arafah, Ali T. Al Hinai, Ali T. Al-Hinai, Abdullah Shehab, Omer Al Tamimi, Omer Al Tamimi, Mahmoud Al Awadhi, Mahmoud Al Awadhi, Shorook Al Herz, Shorook Al Herz, Faisal Al Anazi and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Atherogenic dyslipidemia is highly prevalent in the Arabian Gulf. Non–high-density lipoprotein cholesterol (HDL-C) reduction has been proposed as an additional goal to low-density lipoprotein cholesterol lowering to prevent atherosclerotic cardiovascular disease (ASCVD). Data on non–HDL-C goal attainment in patients with high triglycerides (TGs) on lipid-lowering drugs (LLDs) in the region is scarce.